Patent Grant
11291558
The present invention relates to medical implants, and in particular to medical implants using a fixation plate.
Medical implants can be implanted in a fixed position within a body through a variety of means. For example, bone fusion implants may be anchored to a patient's bone through the use of a bone screw.
Disclosed herein is a dynamic implant fixation plate (hereinafter “fixation plate”) that can, in some embodiments, allow motion relative to an implant after implantation. In some embodiments, the fixation plate can rotate or move relative to an implant and/or relative to a patient's tissue after implantation. In some embodiments, the fixation plate can allow axial compression relative to an implant after implantation. As used herein, the term “tissue” refers to any type of biological, natural or synthetic, tissue, including but not limited to muscle tissue, epithelial tissue, connective tissue, nervous tissue and bony structures.
In the embodiment of the fixation plate presented, the fixation plate can be attached to the implant so that the fixation plate has at least one degree of freedom relative to the implant. As used herein, a “degree of freedom” refers to a direction in which independent motion may occur, however small that motion may be. The fixation plate can also be attached to a first bone and/or a second bone, each attachment with at least one degree of freedom. In some embodiments, the fixation plate can be attached to an implant and/or tissue so that the fixation plate has more than one degree of freedom relative to its respective attachment point. In some embodiments, the fixation plate can be attached to a first bone and/or a second bone with a conical degree of freedom.
Some embodiments of the fixation plate have screw holes with a concave profile and are attached to a patient's bone using a bone screw with a screw head having a convex profile, corresponding to the concave profile of the screw holes, when viewed from the side on the end of the screw head oriented towards the threaded portion. The use of a screw head with a convex profile and a screw hole with a concave profile can provide a fixation with at least a conical degree of freedom. The bone screw head can also be fixed relative to the fixation plate screw holes with a clearance fit of greater than zero that can provide, in some respects, an amount of translational motion and prevent binding between the bone screw head and fixation plate screw holes.
The fixation plate can be attached to an implant using a fastening means with at least one degree of freedom. Some embodiments of the fixation plate use a fastening means with a clearance fit of greater than zero between the fixation plate and an implant that can provide, in some respects, an amount of translational motion and prevent binding between the fixation plate, the implant and/or the fastening means. Some fastening means that could be used include, but are not limited to, quarter turn fasteners, screws, etc.
The fixation plate can be configured for use in bone fusion implants where an implant is fixed to one or more bony structures. Attached using anchors that allow at least one degree of freedom, the fixation plate does not significantly hinder axial compression relative to the implant, where axial relative to the implant is the direction between a first bone and a second bone. Some embodiments use at least a conical degree of freedom to allow loading beyond that purely in the axial direction.
The disclosed fixation plate can be used in situations where it is desirable to avoid stress shielding an implant. The use of a rigid attachment between an implant and a patient's bone can shield the new bone growth and existing bone from stress, resulting in weaker new bone growth and possible bone loss. The disclosed fixation plates transfer the load to the implant, rather than carrying the load, ensuring that the implant's modulus of elasticity and footprint largely determines the amount of axial compression allowed at the implant site.
Despite allowing axial movement, the disclosed fixation plate can adequately prevent lateral or fore and aft movement. When used with an implant that provides sufficient axial stability for new bone growth, the disclosed fixation plate can provide adequate stability in directions other than the axial to permit new bone to grow.
In many situations, it is desirable to use an implant that is capable of bone attachment or osteointegration over time. It is also desirable in many situations to use an implant that is capable of attachment or integration with living tissue. Examples of implants where attachment to bone or osteointegration is beneficial include, but are not limited to, cervical, lumbar, and thoracic interbody fusion implants, vertebral body replacements, osteotomy wedges, dental implants, bone stems, acetabular cups, cranio-facial plating, bone replacement and fracture plating. In many applications, it is also desirable to stress new bone growth to increase its strength. According to Wolff s law, bone will adapt to stresses placed on it so that bone under stress will grow stronger and bone that isn't stressed will become weaker.
In some aspects, the systems and methods described herein can be directed toward implants that are configured for osteointegration and stimulating adequately stressed new bone growth. Many of the exemplary implants of the present invention are particularly useful for use in situations where it is desirable to have strong bone attachment and/or bone growth throughout the body of an implant. Whether bone growth is desired only for attachment or throughout an implant, the present invention incorporates a unique lattice structure that can provide mechanical spacing, a scaffold to support new bone growth and a modulus of elasticity that allows new bone growth to be loaded with physiological forces. As a result, the present invention provides implants that grow stronger and healthier bone for more secure attachment and/or for a stronger bone after the implant osteointegrates.
The exemplary embodiments of the invention presented can be comprised, in whole or in part, of a lattice. A lattice, as used herein, refers to a three-dimensional material with one or more interconnected openings that allow a fluid to communicate from one location to another location through an opening. A three-dimensional material refers to a material that fills a three-dimensional space (i.e. has height, width and length). Lattices can be constructed by many means, including repeating various geometric shapes or repeating random shapes to accomplish a material with interconnected openings. An opening in a lattice is any area within the bounds of the three-dimensional material that is devoid of that material. Therefore, within the three-dimensional boundaries of a lattice, there is a volume of material and a volume that is devoid of that material.
The material that provides the structure of the lattice is referred to as the primary material. The structure of a lattice does not need to provide structural support for any purpose, but rather refers to the configuration of the openings and interconnections that comprise the lattice. An opening in a lattice may be empty, filled with a gaseous fluid, filled with a liquid fluid, filled with a solid or partially filled with a fluid and/or solid. Interconnections, with respect to openings, refer to areas devoid of the primary material and that link at least two locations together. Interconnections may be configured to allow a fluid to pass from one location to another location.
A lattice can be defined by its volumetric density, meaning the ratio between the volume of the primary material and the volume of voids presented as a percentage for a given three-dimensional material. The volume of voids is the difference between the volume of the bounds of the three-dimensional material and the volume of the primary material. The volume of voids can comprise of the volume of the openings, the volume of the interconnections and/or the volume of another material present. For example, a lattice with a 30% volumetric density would be comprised of 30% primary material by volume and 70% voids by volume over a certain volume. A lattice with a 90% volumetric density would be comprised of 90% primary material by volume and 10% voids by volume over a certain volume. In three-dimensional materials with a volumetric density of less than 50%, the volume of the primary material is less than the volume of voids. While the volumetric density refers to the volume of voids, the voids do not need to remain void and can be filled, in whole or in part, with a fluid or solid prior to, during or after implantation.
Lattices comprised of repeating geometric patterns can be described using the characteristics of a repeating unit cell. A unit cell in a repeating geometric lattice is a three-dimensional shape capable of being repeated to form a lattice. A repeating unit cell can refer to multiple identical unit cells that are repeated over a lattice structure or a pattern through all or a portion of a lattice structure. Each unit cell is comprised of a certain volume of primary material and a certain void volume, or in other words, a spot volumetric density. The spot volumetric density may cover as few as a partial unit cell or a plurality of unit cells. In many situations, the spot volumetric density will be consistent with the material's volumetric density, but there are situations where it could be desirable to locally increase or decrease the spot volumetric density.
Unit cells can be constructed in numerous volumetric shapes containing various types of structures. Unit cells can be bound by a defined volume of space to constrict the size of the lattice structure or other type of structure within the unit cell. In some embodiments, unit cells can be bound by volumetric shapes, including but not limited to, a cubic volume, a cuboid volume, a hexahedron volume or an amorphous volume. The unit cell volume of space can be defined based on a number of faces that meet at corners. In examples where the unit cell volume is a cubic, cuboid or hexahedron volume, the unit cell volume can have six faces and eight corners, where the corners are defined by the location where three faces meet. Unit cells may be interconnected in some or all areas, not interconnected in some or all areas, of a uniform size in some or all areas or of a nonuniform size in some or all areas. In some embodiments disclosed herein that use a repeating geometric pattern, the unit cells can be defined by a number of struts defining the edges of the unit cell and joined at nodes about the unit cell. Unit cells so defined can share certain struts among more than one unit cell, so that two adjacent unit cells may share a common planar wall defined by struts common to both cells. In some embodiments disclosed herein that use a repeating geometric pattern, the unit cells can be defined by a node and a number of struts extending radially from that node.
While the present application uses volumetric density to describe exemplary embodiments, it is also possible to describe them using other metrics, including but not limited to cell size, strut size or stiffness. Cell size may be defined using multiple methods, including but not limited to cell diameter, cell width, cell height and cell volume. Strut size may be defined using multiple methods, including but not limited to strut length and strut diameter.
Repeating geometric patterns are beneficial for use in lattice structures contained in implants because they can provide predictable characteristics. Many repeating geometric shapes may be used as the unit cell of a lattice, including but are not limited to, rhombic dodecahedron, diamond, dodecahedron, square, pentagonal, hexagonal, octagonal, sctet struts, trunic octa, diagonal struts, other known geometric structures, and rounded, reinforced, weakened, or simplified versions of each geometry.
Lattices may also be included in implants as a structural component or a nonstructural component. Lattices used in structural applications may be referred to herein as structural lattices, load-bearing lattices or stressed lattices. In some instances, structural lattices, load-bearing lattices or stressed lattices may be simply referred to as a lattice. Repeating geometric shaped unit cells, particularly the rhombic dodecahedron, are well suited, in theory, for use in structural lattices because of their strength to weight ratio. To increase the actual strength and fatigue resistance of a rhombic dodecahedron lattice, the present invention, in some embodiments, includes a modified strut comprised of triangular segments, rather than using a strut with a rectangular or circular cross section. Some embodiments herein also modify the angles defining the rhombic faces of a rhombic dodecahedron to change the lattice's elastic modulus and fatigue resistance. The use of triangular segments provides a lattice with highly predictable printed properties that approach the theoretical strength values for a rhombic dodecahedron lattice.
In structural lattice applications, the strength and elastic modulus of the lattice can be approximated by the volumetric density. When the volumetric density increases, the strength and the elastic modulus increases. Compared to other porous structures, the lattice of the present invention has a higher strength and elastic modulus for a given volumetric density because of its ability to use the high strength to weight benefits of a rhombic dodecahedron, modified rhombic dodecahedron or radial dodeca-rhombus unit cell.
The term “elastic modulus,” as used herein, can refer to either the elastic modulus of a material or the effective elastic modulus of a volume of material. An elastic modulus quantifies a material or volume of material's resistance to elastic deformation in response to a stress. A volume of material can have an elastic modulus of the material itself and an effective elastic modulus of the entire volume of material. An effective elastic modulus can be determined by compressing the volume of material and treating it as a homogenous material for the purposes of calculating the effective elastic modulus. When the term “elastic modulus” is used herein, it can refer to both or either of the elastic modulus of a material or the effective elastic modulus of a volume of material.
When configured to provide support for bone or tissue growth, a lattice may be referred to as a scaffold. Lattices can be configured to support bone or tissue growth by controlling the size of the openings and interconnections disposed within the three-dimensional material. A scaffold, if used on the surface of an implant, may provide an osteointegration surface that allows adjacent bone to attach to the implant. A scaffold may also be configured to provide a path that allows bone to grow further than a mere surface attachment. Scaffolds intended for surface attachment are referred to herein as surface scaffolds. A surface scaffold may be one or more unit cells deep, but does not extend throughout the volume of an implant. Scaffolds intended to support in-growth beyond mere surface attachment are referred to herein as bulk scaffolds. Scaffolds may also be included in implants as a structural component or a nonstructural component. Scaffolds used in structural applications may be referred to herein as structural scaffolds, load-bearing scaffolds or stressed scaffolds. In some instances, structural scaffolds, load-bearing scaffolds or stressed scaffolds may be simply referred to as a scaffold. In some instances, the use of the term scaffold may refer to a material configured to provide support for bone or tissue growth, where the material is not a lattice.
The scaffolds described herein can be used to promote the attachment or in-growth of various types of tissue found in living beings. As noted earlier, some embodiments of the scaffold are configured to promote bone attachment and in-growth. The scaffolds can also be configured to promote attachment of in-growth of other areas of tissue, such as fibrous tissue. In some embodiments, the scaffold can be configured to promote the attachment or in-growth of multiple types of tissue. Some embodiments of the scaffolds are configured to be implanted near or abutting living tissue. Near living tissue includes situations where other layers, materials or coatings are located between a scaffold and any living tissue.
In some embodiments, the present invention uses bulk scaffolds with openings and interconnections that are larger than those known in the art. Osteons can range in diameter from about 100 μm and it is theorized that a bundle of osteons would provide the strongest form of new bone growth. Bone is considered fully solid when it has a diameter of greater than 3 mm so it is theorized that a bundle of osteons with a diameter equaling approximately half of that value would provide significant strength when grown within a scaffold. It is also theorized that osteons may grow in irregular shapes so that the cross-sectional area of an osteon could predict its strength. A cylindrical osteon growth with a 3 mm diameter has a cross-sectional area of approximately 7 square mm and a cylindrical osteon with a 1.5 mm diameter has a cross-sectional area of 1.8 square mm. It is theorized that an osteon of an irregular shape with a cross-sectional area of at least 1.8 square millimeters could provide a significant strength advantage when grown in a scaffold.
Most skilled in the art would indicate that pores or openings with a diameter or width between 300 μm to 900 μm, with a pore side of 600 μm being ideal, provide the best scaffold for bone growth. Instead, some embodiments of the present invention include openings and interconnections with a diameter or width on the order of 1.0 to 15.0 times the known range, with the known range being 300 μm to 900 μm, resulting in openings from 0.07 mm2 up to 145 mm2 cross sectional area for bone growth. In some examples, pores or openings with a diameter or width between and including 100 μm to 300 μm could be beneficial. Some examples include openings and interconnections with a diameter on the order of 1.0 to 5.0 times the known range. It has been at least theorized that the use of much larger openings and interconnections than those known in the art will allow full osteons and solid bone tissue to form throughout the bulk scaffold, allowing the vascularization of new, loadable bone growth. In some examples, these pores may be 3 mm in diameter or approximately 7 mm2 in cross sectional area. In other examples, the pores are approximately 1.5 mm in diameter or approximately 1.75 mm2 in cross sectional area. The use of only the smaller diameter openings and interconnections known in the art are theorized to limit the penetration of new bone growth into a bulk scaffold because the smaller diameter openings restrict the ability of vascularization throughout the bulk scaffold.
A related structure to a lattice is a closed cell material. A closed cell material is similar to a lattice, in that it has openings contained within the bounds of a three-dimensional material, however, closed cell materials generally lack interconnections between locations through openings or other pores. A closed cell structure may be accomplished using multiple methods, including the filling of certain cells or through the use of solid walls between the struts of unit cells. A closed cell structure can also be referred to as a cellular structure. It is possible to have a material that is a lattice in one portion and a closed cell material in another. It is also possible to have a closed cell material that is a lattice with respect to only certain interconnections between openings or vice versa. While the focus of the present disclosure is on lattices, the structures and methods disclosed herein can be easily adapted for use on closed cell structures within the inventive concept.
The lattice used in the present invention can be produced from a range of materials and processes. When used as a scaffold for bone growth, it is desirable for the lattice to be made of a biocompatible material that allows for bone attachment, either to the material directly or through the application of a bioactive surface treatment. In one example, the scaffold is comprised of an implantable metal. Implantable metals include, but are not limited to, zirconium, stainless steel (316 & 316L), tantalum, nitinol, cobalt chromium alloys, titanium and tungsten, and alloys thereof. Scaffolds comprised of an implantable metal may be produced using an additive metal fabrication or 3D printing process. Appropriate production processes include, but are not limited to, direct metal laser sintering, selective laser sintering, selective laser melting, electron beam melting, laminated object manufacturing and directed energy deposition.
In another example, the lattice of the present invention is comprised of an implantable metal with a bioactive coating. Bioactive coatings include, but are not limited to, coatings to accelerate bone growth, anti-thrombogenic coatings, anti-microbial coatings, hydrophobic or hydrophilic coatings, and hemophobic, superhemophobic, or hemophilic coatings. Coatings that accelerate bone growth include, but are not limited to, calcium phosphate, hydroxyapatite (“HA”), silicate glass, stem cell derivatives, bone morphogenic proteins, titanium plasma spray, titanium beads and titanium mesh. Anti-thrombogenic coatings include, but are not limited to, low molecular weight fluoro-oligomers. Anti-microbial coatings include, but are not limited to, silver, organosilane compounds, iodine and silicon-nitride. Superhemophobic coatings include fluorinated nanotubes.
In another example, the lattice is made from a titanium alloy with an optional bioactive coating. In particular, Ti6Al4V ELI wrought (American Society for Testing and Materials (“ASTM”) F136) is a particularly well-suited titanium alloy for scaffolds. While Ti6Al4V ELI wrought is the industry standard titanium alloy used for medical purposes, other titanium alloys, including but not limited to, unalloyed titanium (ASTM F67), Ti6Al4V standard grade (ASTM F1472), Ti6Al7Nb wrought (ASTM 1295), Ti5Al2.5Fe wrought (British Standards Association/International Standard Organization Part 10), CP and Ti6Al4V standard grade powders (ASTM F1580), Ti13Nb13Zr wrought (ASTM F1713), the lower modulus Ti-24Nb-4Zr-8Sn and Ti12Mo6Zr2Fe wrought (ASTM F1813) can be appropriate for various embodiments of the present invention.
Titanium alloys are an appropriate material for scaffolds because they are biocompatible and allow for bone attachment. Various surface treatments can be done to titanium alloys to increase or decrease the level of bone attachment. Bone will attach to even polished titanium, but titanium with a surface texture allows for greater bone attachment. Methods of increasing bone attachment to titanium may be produced through a forging or milling process, sandblasting, acid etching, and the use of a bioactive coating. Titanium parts produced with an additive metal fabrication or 3D printing process, such as direct metal laser sintering, can be treated with an acid bath to reduce surface stress risers, normalize surface topography, and improve surface oxide layer, while maintaining surface roughness and porosity to promote bone attachment.
Additionally, Titanium or other alloys may be treated with heparin, heparin sulfate (HS), glycosaminoglycans (GAG), chondroitin-4-sulphate (C4S), chondroitin-6-sulphate (C6S), hyaluronan (HY), and other proteoglycans with or without an aqueous calcium solution. Such treatment may occur while the material is in its pre-manufacturing form (often powder) or subsequent to manufacture of the structure.
While a range of structures, materials, surface treatments and coatings have been described, it is believed that a lattice using a repeating modified rhombic dodecahedron (hereinafter “MRDD”) unit cell can present a preferable combination of stiffness, strength, fatigue resistance, and conditions for bone ingrowth. In some embodiments, the repeating MRDD lattice is comprised of titanium or a titanium alloy. A generic rhombic dodecahedron (hereinafter “RDD”), by definition, has twelve sides in the shape of rhombuses. When repeated in a lattice, an RDD unit cell is comprised of 24 struts that meet at 14 vertices. The 24 struts define the 12 planar faces of the structure and disposed at the center of each planar face is an opening, or interconnection, allowing communication from inside the unit cell to outside the unit cell.
An example of the MRDD unit cell B10 used in the present invention is shown in
In some embodiments of the MRDD, each node is contained within a fixed volume that defines its bounds and provides a fixed point in space for the distal ends of the struts. The fixed volume containing the MRDD or a sub-unit cell of the MRDD can be various shapes, including but not limited to, a cubic, cuboid, hexahedron or amorphous volume. Some examples use a fixed volume with six faces and eight corners defined by locations where three faces meet. The orientation of the struts can be based on the center of a node face at its proximate end and the nearest corner of the volume to that node face on its distal end. Each node is preferably an octahedron, more specifically a square bipyramid (i.e. a pyramid and inverted pyramid joined on a horizontal plane). Each node, when centrally located in a cuboid volume, more preferably comprises a square plane parallel to a face of the cuboid volume, six vertices and is oriented so that each of the six vertices are positioned at their closest possible location to each of the six faces of the cuboid volume. Centrally located, with regards to the node's location within a volume refers to positioning the node at a location substantially equidistant from opposing walls of the volume. In some embodiments, the node can have a volumetric density of 100 percent and in other embodiments, the node can have a volumetric density of less than 100 percent. Each face of the square bipyramid node can be triangular and each face can provide a connection point for a strut.
The struts can also be octahedrons, comprising an elongate portion of six substantially similar elongate faces and two end faces. The elongate faces can be isosceles triangles with a first internal angle, angle A, and a second internal angle, angle B, where angle B is greater than angle A. The end faces can be substantially similar isosceles triangles to one another with a first internal angle, angle C, and a second internal angle, angle D, where angle D is greater than angle C. Preferably, angle C is greater than angle A.
The strut direction of each strut is a line or vector defining the orientation of a strut and it can be orthogonal or non-orthogonal relative to the planar surface of each node face. In the MRDD and radial dodeca-rhombus structures disclosed herein, the strut direction can be determined using a line extending between the center of the strut end faces, the center of mass along the strut or an external edge or face of the elongate portion of the strut. When defining a strut direction using a line extending between the center of the strut end faces, the line is generally parallel to the bottom face or edge of the strut. When defining a strut direction using a line extending along the center of mass of the strut, the line can be nonparallel to the bottom face or edge of the strut. The octahedron nodes of the MRDD can be scaled to increase or decrease volumetric density by changing the origin point and size of the struts. The distal ends of the struts, however, are locked at the fixed volume corners formed about each node so that their angle relative to each node face changes as the volumetric density changes. Even as the volumetric density of an MRDD unit cell changes, the dimensions of the fixed volume formed about each node does not change. In
In some embodiments, the strut direction of a strut can intersect the center of the node and the corner of the cuboid volume nearest to the node face where the strut is fixed. In some embodiments, the strut direction of a strut can intersect just the corner of the cuboid volume nearest to the node face where the strut is fixed. In some embodiments, a reference plane defined by a cuboid or hexahedron face is used to describe the strut direction of a strut. When the strut direction of a strut is defined based on a reference plane, it can be between 0 degrees and 90 degrees from the reference plane. When the strut direction of a strut is defined based on a reference plane, it is preferably eight degrees to 30 degrees from the reference plane.
By indexing the strut orientation to a variable node face on one end and a fixed point on its distal end, the resulting MRDD unit cell can allow rhombus shaped faces with a smaller acute angle and larger obtuse angle than a generic RDD. The rhombus shaped faces of the MRDD can have two substantially similar opposing acute angles and two substantially similar opposing obtuse angles. In some embodiments, the acute angles are less than 70.5 degrees and the obtuse angles are greater than 109.5 degrees. In some embodiments, the acute angles are between 0 degrees and 55 degrees and the obtuse angles are between 125 degrees and 180 degrees. In some embodiments, the acute angles are between 8 degrees and 60 degrees and the obtuse angles are between 120 degrees and 172 degrees. The reduction in the acute angles increases fatigue resistance for loads oriented across the obtuse angle corner to far obtuse angle corner. The reduction in the acute angles and increase in obtuse angles also orients the struts to increase the MRDD's strength in shear and increases the fatigue resistance. By changing the rhombus corner angles from a generic RDD, shear loads pass substantially in the axial direction of some struts, increasing the shear strength. Changing the rhombus corner angles from a generic RDD also reduces overall deflection caused by compressive loads, increasing the fatigue strength by resisting deflection under load.
When placed towards the center of a lattice structure, the 12 interconnections of a unit cell connect to 12 different adjacent unit cells, providing continuous paths through the lattice. The size of the central void and interconnections in the MRDD may be defined using the longest dimension method as described herein. Using the longest dimension method, the central void can be defined by taking a measurement of the longest dimension as demonstrated in
The size of the central void and interconnections can alternatively be defined by the largest sphere method as described herein. Using the largest sphere method, the central void can be defined by the diameter of the largest sphere that can fit within the central void without intersecting the struts. In
Using the alternative measuring method, in some examples, the width of the interconnections is approximately 600 μm and the length of the interconnections is approximately 300 μm. The use of a 600 μm length and 300 μm width provides an opening within the known pore sizes for bone growth and provides a surface area of roughly 1.8 square millimeters, allowing high strength bone growth to form. Alternative embodiments may contain interconnections with a cross sectional area of 1.0 to 15.0 times the cross-sectional area of a pore with a diameter of 300 μm. Other embodiments may contain interconnections with a cross sectional area of 1.0 to 15.0 times the cross-sectional area of a pore with a diameter of 900 μm.
The MRDD unit cell also has the advantage of providing at least two sets of substantially homogenous pore or opening sizes in a lattice structure. In some embodiments, a first set of pores have a width of about 200 μm to 900 μm and a second set of pores have a width of about 1 to 15 times the width of the first set of pores. In some embodiments, a first set of pores can be configured to promote the growth of osteoblasts and a second set of pores can be configured to promote the growth of osteons. Pores sized to promote osteoblast growth can have a width of between and including about 100 μm to 900 μm. In some embodiments, pores sized to promote osteoblast growth can have a width that exceeds 900 μm. Pores sized to promote the growth of osteons can have a width of between and including about 100 μm to 13.5 mm. In some embodiments, pores sized to promote osteon growth can have a width that exceeds 13.5 mm.
In some embodiments, it is beneficial to include a number of substantially homogenous larger pores and a number of substantially homogenous smaller pores, where the number of larger pores is selected based on a ratio relative to the number of smaller pores. For example, some embodiments have one large pore for every one to 25 small pores in the lattice structure. Some embodiments preferably have one large pore for every eight to 12 smaller pores. In some embodiments, the number of larger and smaller pores can be selected based on a percentage of the total number of pores in a lattice structure. For example, some embodiments can include larger pores for four percent to 50 percent of the total number of pores and smaller pores for 50 percent to 96 percent of the total number of pores. More preferably, some embodiments can include larger pores for about eight percent to 13 percent of the total number of pores and smaller pores for about 87 percent to 92 percent of the total number of pores. It is believed that a lattice constructed with sets of substantially homogenous pores of the disclosed two sizes provides a lattice structure that simultaneously promotes osteoblast and osteon growth.
The MRDD unit cell may also be defined by the size of the interconnections when viewed from a side, top or bottom of a unit cell. The MRDD unit cell has the same appearance when viewed from a side, top or bottom, making the measurement in a side view representative of the others. When viewed from the side, as in
In some embodiments of the lattice structures disclosed herein, the central void is larger than the length or width of the interconnections. Because the size of each interconnection can be substantially the same in a repeating MRDD structure, the resulting lattice can be comprised of openings of at least two discrete sizes. In some embodiments, it is preferable for the diameter of the central void to be approximately two times the length of the interconnections. In some embodiments, it is preferable for the diameter of the central void to be approximately four times the width of the interconnections.
In some embodiments, the ratio between the diameter of the central void and the length or width of the interconnections can be changed to create a structural lattice of a particular strength. In these embodiments, there is a correlation where the ratio between the central void diameter and the length or width of the interconnections increases as the strength of the structural lattice increases.
It is also believed that a lattice using a repeating radial dodeca-rhombus (hereinafter “RDDR”) unit cell can present a preferable combination of stiffness, strength, fatigue resistance, and conditions for bone ingrowth. In some embodiments, the repeating RDDR lattice is comprised of titanium or a titanium alloy. In
As used herein, an RDDR unit cell B20 is a three-dimensional shape comprised of a central node with radial struts and mirrored struts thereof forming twelve rhombus shaped structures. The node is preferably an octahedron, more specifically a square bipyramid (i.e. a pyramid and inverted pyramid joined on a horizontal plane). Each face of the node is preferably triangular and fixed to each face is a strut comprised of six triangular facets and two end faces. The central axis of each strut can be orthogonal or non-orthogonal relative to the planar surface of each node face. The central axis may follow the centroid of the strut. The RDDR is also characterized by a central node with one strut attached to each face, resulting in a square bipyramid node with eight struts attached.
Examples of node and strut combinations are shown in
In
In
Adjacent struts extending from adjacent node faces on either the upper half or lower half of the node have an angle from the horizontal plane and a lateral separation angle defined by an angle between the strut directions of adjacent struts. In the MRDD and RDDR structures, adjacent struts have an external edge or face of the elongate portion extending closest to the relevant adjacent strut. The lateral separation angle, as used herein, generally refers to the angle between an external edge or face of the elongate portion of a strut extending closest to the relevant adjacent strut. In some embodiments, a lateral separation angle defined by a line extending between the center of the strut end faces or a line defined by the center of mass of the struts can be used in reference to a similar calculation for an adjacent strut.
The lateral separation angle is the angle between the nearest face or edge of a strut to an adjacent strut. The lateral separation angle can be measured as the smallest angle between the nearest edge of a strut to the nearest edge of an adjacent strut, in a plane containing both strut edges. The lateral separation angle can also be measured as the angle between the nearest face of a strut to the nearest face of an adjacent strut in a plane normal to the two strut faces. In embodiments without defined strut edges or strut faces, the lateral separation angle can be measured as an angle between the nearest portion of one strut to the nearest portion of an adjacent strut. For a unit cell in a cubic volume, as the strut angle from the horizontal plane decreases, the lateral separation angle approaches 90 degrees. For a unit cell in a cubic volume, as the strut angle from the horizontal plane increases, the lateral separation angle approaches 180 degrees. In some embodiments, it is preferable to have a lateral separation angle greater than 109.5 degrees. In some embodiments, it is preferable to have a lateral separation angle of less than 109.5 degrees. In some embodiments, it is preferable to have a lateral separation angle of between and including about 108 degrees to about 156 degrees. In some embodiments, it is more preferable to have a lateral separation angle of between and including 111 degrees to 156 degrees. In some embodiments, it is more preferable to have a lateral separation angle of between and including 108 degrees to 120 degrees. In some embodiments, it is most preferable to have a lateral separation angle of between and including about 111 degrees to 120 degrees. In some embodiments, it is more preferable to have a lateral separation angle of between and including 128 degrees to 156 degrees. In
In some embodiments, a unit cell is built up from multiple sub-unit cells fixed together. In
In
On the lower face of the node B530 opposite the face which strut B531 is fixed, the proximate end of strut B534 is fixed to the node B530. The strut B534 extends to the nearest corner of cubic volume B532 at its distal end. The strut B535 is fixed on its proximate end to an upper node B530 face directed about 90 degrees laterally from the node B530 face fixed to strut B531. The strut B535 extends to the nearest corner of the cubic volume B532 at its distal end. On the upper face of the node B530 opposite the face which strut B535 is fixed, the proximate end of strut B536 is fixed to the node B530. The strut B536 extends to the nearest corner of the cubic volume B532 at its distal end.
In some embodiments, the struts B531 & B534-B536 are octahedrons with triangular faces. The strut face fixed to a node B530 face can be substantially the same size and orientation of the node B530 face. The strut face fixed to the nearest corner of the cube B532 can be substantially the same size as the strut face fixed to the node B530 and oriented on a substantially parallel plane. The remaining six faces can be six substantially similar isosceles triangles with a first internal angle and a second internal angle larger than said first internal angle. The six substantially similar isosceles triangles can be fixed along their long edges to an adjacent and inverted substantially similar isosceles triangle to form a generally cylindrical shape with triangular ends.
When forming a sub-unit cell B540, it can be beneficial to add an eighth node B538 to each corner of the cube B532 fixed to a strut B531 & B534-B536. When replicating the sub-unit cell B540, the eighth node B538 attached to each strut end is combined with eighth nodes from adjacent sub-unit cells to form nodes located between the struts of adjacent sub-unit cells.
In
The first sub-unit B540 is used as the datum point in the embodiment of
Alternatively, a full unit cell can be built up by fixing a first group of four substantially similar sub-unit cells together laterally to form a square, rectangle or quadrilateral when viewed from above. A second group of four substantially similar sub-unit cells rotated about their central axis can be fixed together laterally to also form a square, rectangle or quadrilateral when viewed from above. The second group of sub-unit cells can be rotated about their central axis prior to being fixed together laterally or inverted after being fixed together to achieve the same result. The second group is then fixed to the top of the first group to form a full unit cell.
In
Each strut extending from the node, for a given unit cell, can be substantially the same length and angle from the horizontal plane, extending radially from the node. At the end of each strut, the strut is mirrored so that struts extending from adjacent node faces form a rhombus shaped opening. Because the struts can be non-orthogonal to the node faces, rhombuses of two shapes emerge. In this configuration, a first group of four rhombuses extend radially from the node oriented in vertical planes. The acute angles of the first group of rhombuses equal twice the strut angle from the horizontal plane and the obtuse angles equal 180 less the acute angles. Also in this configuration is a second group of eight rhombuses extending radially so that a portion of the second group of eight rhombuses fall within the lateral separation angle between adjacent struts defining the first group of four rhombuses. The acute angles of the second group of rhombuses can be about the same as the lateral separation angle between adjacent struts that define the first group of four rhombuses and the obtuse angles equal 180 less the acute angles. The characteristics of a scaffold may also be described by its surface area per volume. For a 1.0 mm×1.0 mm×1.0 mm solid cube, its surface area is 6.0 square mm. When a 1.0 cubic mm structure is comprised of a lattice structure rather than a 100 percent volumetric density material, the surface area per volume can increase significantly. In low volumetric density scaffolds, the surface area per volume increases as the volumetric density increases. In some embodiments, a scaffold with a volumetric density of 30.1 percent would have a surface area of 27.4 square mm per cubic mm. In some embodiments, if the volumetric density was decreased to 27.0 percent, the lattice would have a surface area of 26.0 square mm per cubic mm and if the volumetric density were decreased to 24.0 percent, the lattice would have a surface area of 24.6 square mm per cubic mm.
The MRDD and RDDR structures disclosed herein also have the advantage of an especially high modulus of elasticity for a given volumetric density. When used as a lattice or scaffold, an implant with an adequate modulus of elasticity and a low volumetric density can be achieved. A low volumetric density increases the volume of the implant available for bone ingrowth.
In Table 1, below, are a number of example lattice configurations of various lattice design elastic moduli. An approximate actual elastic modulus was given for each example, representing a calculated elastic modulus for that lattice after going through the manufacturing process. The lattice structures and implants disclosed herein can be designed to a design elastic modulus in some embodiments and to an approximate actual elastic modulus in other embodiments. One advantage of the presently disclosed lattice structures is that the approximate actual elastic modulus is much closer to the design elastic modulus than has been previously achieved. During testing, one embodiment of a lattice was designed for a 4.0 GPa design elastic modulus. Under testing, the lattice had an actual elastic modulus of 3.1 GPa, achieving an actual elastic modulus within 77 percent of the design elastic modulus.
For each lattice design elastic modulus, a volumetric density, ratio of design elastic modulus to volumetric density, surface area in mm2, ratio of surface area to volumetric density and ratio of surface area to lattice design elastic modulus is given.
In some of the embodiments disclosed herein, the required strut thickness can be calculated from the desired modulus of elasticity. Using the following equation, the strut thickness required to achieve a particular elastic modulus can be calculated for some MRDD and RDDR structures:
Strut Thickness=(−0.0035*(E{circumflex over ( )}2))+(0.0696*E)+0.4603
In the above equation, “E” is the modulus of elasticity. The modulus of elasticity can be selected to determine the required strut thickness required to achieve that value or it can be calculated using a preselected strut thickness. The strut thickness is expressed in mm and represents the diameter of the strut. The strut thickness may be calculated using a preselected modulus of elasticity or selected to determine the modulus of elasticity for a preselected strut thickness.
In some embodiments, the unit cell can be elongated in one or more directions to provide a lattice with anisotropic properties. When a unit cell is elongated, it generally reduces the elastic modulus in a direction normal to the direction of the elongation. The elastic modulus in the direction of the elongation is increased. It is desirable to elongate cells in the direction normal to the direction of new bone growth contained within the interconnections, openings and central voids (if any). By elongating the cells in a direction normal to the desired direction of reduced elastic modulus, the shear strength in the direction of the elongation may be increased, providing a desirable set of qualities when designing a structural scaffold. Covarying the overall stiffness of the scaffold may augment or diminish this effect, allowing variation in one or more directions.
In some embodiments, the sub-unit cells may be designing by controlling the height of the node relative to the height of the volume that defines the sub-unit cell. Controlling the height of the node can impact the final characteristics and appearance of the lattice structure. In general, increasing the height of the node increases the strut thickness, increases the volumetric density, increases the strength and increases the elastic modulus of the resulting lattice. When increasing the height of the node, the width of the node can be held constant in some embodiments or varied in other embodiments.
In some embodiments, the sub-unit cells may be designing by controlling the volume of the node relative to the volume that defines the sub-unit cell. Controlling the volume of the node can impact the final characteristics and appearance of the lattice structure. In general, increasing the volume of the node increases the strut thickness, increases the volumetric density, increases the strength and increases the elastic modulus of the resulting lattice. When increasing the volume of the node, the width or height of the node could be held constant in some embodiments.
In Table 2, below, are a number of example lattice configurations of various lattice design elastic moduli. An approximate actual elastic modulus was given for each example, representing a calculated elastic modulus for that lattice after going through the manufacturing process. The lattice structures and implants disclosed herein can be designed to a design elastic modulus in some embodiments and to an approximate actual elastic modulus in some embodiments. For each lattice design elastic modulus, a lattice approximate elastic modulus, a node height, a volumetric density, a node volume, a ratio of node height to volumetric density, a ratio of node height to lattice design elastic modulus and a ratio of volumetric density to node volume is given.
Some embodiments of the disclosed lattice structures are particularly useful when provided within an elastic modulus range between an including 0.375 GPa to 4 GPa. Some embodiments, more preferably, include a lattice structure with an elastic modulus between and including 2.5 GPa to 4 GPa. Some embodiments include a lattice structure with a volumetric density between and including five percent to 40 percent. Some embodiments, more preferably, include a lattice structure with a volumetric density between and including 30 percent to 38 percent.
The lattice structures disclosed herein have particularly robust loading and fatigue characteristics for low volumetric density ranges and low elastic moduli ranges. Some embodiments of the lattice structures have a shear yield load and a compressive yield load between and including 300 to 15000N in static and dynamic loading up to 5,000,000 cycles at 5 Hz. Some embodiments have a compressive shear strength and an axial load between and including 300 to 15000N in static and dynamic loading up to 5,000,000 cycles at 5 Hz. Some embodiments have a shear strength and an axial load between and including 300 to 15000N in static and dynamic loading up to 5,000,000 cycles at 5 Hz. Some embodiments have a torsional yield load up to 15 Nm.
In one example, the inventive lattice structure has a volumetric density of between and including 32 percent to 38 percent, an elastic modulus between and including 2.5 GPa to 4 GPa and a shear strength and an axial load between and including 300 to 15000N in static and dynamic loading up to 5,000,000 cycles at 5 Hz. Some examples include a first set of substantially homogeneous openings with a width of about 200 μm to 900 μm and a second set of substantially homogenous openings with a width of about 1 to 15 times the width of the first set of openings, where the number of openings in the second set are provided at a ratio of about 1:8 to 1:12 relative to the number of openings in the first set.
The disclosed structures can also have benefits when used in applications where osteointegration is not sought or undesirable. By including a growth inhibiting coating or skin on a structure, the lattice disclosed herein can be used to provide structural support without providing a scaffold for bone growth. This may be desirable when used in temporary implants or medical devices that are intended to be removed after a period of time.
Disclosed herein is a first exemplary embodiment of a fixation plate 10 configured for use with an exemplary implant 20. The fixation plate can be configured to work with multiple types of implants, including but not limited to, bone fusion implants and interbody fusion implants. In some embodiments, the implant 20 is a cervical stand-alone (hereinafter “CSA”) implant. In some embodiments, the implant 20 is an Anterior Lumbar Interbody Fusion Stand-Alone (hereinafter “ALIF-SA”) implant. In some embodiments, the implant 20 is a Posterior Lumbar Interbody Fusion (hereinafter “PLIF”) implant. In some embodiments, the implant 20 is a Transforaminal Lumbar Interbody Fusion (hereinafter “TLIF”) implant. In some embodiments, the implant 20 is a PLIF or TLIF implant. In some embodiments, the implant 20 is an Anterior Lumbar Interbody Fusion (hereinafter “ALIF”) implant. In some embodiments, the implant 20 is a vertebral body replacement (hereinafter “VBR”) implant. In some embodiments, the implant 20 is an osteotomy wedge. In some embodiments, the implant 20 is an ankle fusion spacer implant. In some embodiments, the implant 20 is configured for tissue attachment, tissue including but not limited to bony structures and connective tissue. In some embodiments, the implant 20 is configured to allow tissue in-growth, tissue including but not limited to bony structures and connective tissue.
The fixation plate 10 can be configured to allow motion relative to an implant after implantation and/or relative to a patient's tissue after implantation. In some embodiments, the fixation plate can allow axial compression relative to an implant after implantation. In the embodiment of the fixation plate presented, the fixation plate can be attached to the implant so that the fixation plate has at least one degree of freedom relative to the implant. The fixation plate can also be attached to a first bone and/or a second bone, each attachment with at least one degree of freedom. In some embodiments, the fixation plate can be attached to an implant and/or tissue so that the fixation plate has more than one degree of freedom relative to its respective attachment point. In some embodiments, the fixation plate can be attached to a first bone and/or a second bone with a conical degree of freedom.
Some embodiments of the fixation plate have screw holes with a concave profile and are attached to a patient's bone using a bone screw with a screw head having a convex profile, corresponding to the concave profile of the screw holes, when viewed from the side on the end of the screw head oriented towards the threaded portion. The use of a screw head with a convex profile and a screw hole with a concave profile can provide a fixation with at least a conical degree of freedom. The bone screw head can also be fixed relative to the fixation plate screw holes with a clearance fit of greater than zero that can provide, in some respects, an amount of translational motion and prevent binding between the bone screw head and fixation plate screw holes. A clearance fit, as used herein, refers to a condition where there is a positive difference between the dimensions of assembled components. For example, a clearance fit would be present when the diameter of a screw head is less than its corresponding screw hole.
The fixation plate can be attached to an implant using a fastening means with at least one degree of freedom. Some embodiments of the fixation plate use a fastening means with a clearance fit of greater than zero between the fixation plate and an implant. The use of a fastening means with a clearance fit can provide, in some respects, an amount of translational motion and prevent binding between the fixation plate, the implant and/or the fastening means. Some fastening means that could be used include, but are not limited to, quarter turn fasteners, screws, etc. A clearance fit with respect to a quarter turn fastener can be in an axial and/or radial direction, providing multiple directions for translational motion.
The number of degrees of freedom provided between two given components can be the result of multiple factors, including but not limited to, a designed degree of freedom, a manufacturing tolerance degree of freedom or a clearance fit degree of freedom. The disclosure focuses on a designed degree of freedom and, in some embodiments, an intended clearance fit degree of freedom. However, it is appreciated that manufacturing tolerances can be measured and/or measured and used similarly to create a device with the necessary degree(s) of freedom.
In
In
In some embodiments, the fixation plate 10 is oriented relative to the implant 20 based on a line drawn between the centers of the screw holes 11 relative to a plane passing through the axial center of the implant 20. In some embodiments, the fixation plate 10 is oriented between and including −45 degrees and 45 degrees relative to the implant 20 in an unlocked position. In some embodiments, the fixation plate 10 is oriented between and including 10 degrees and 90 degrees relative to the implant 20 in a locked position. In some embodiments, the fixation plate is oriented between and including −10 degrees and −90 degrees relative to the implant 20 in a locked position.
In
In
The use of a screw head 31 with a convex profile and a screw hole 11 with a concave profile can provide a fixation with at least a conical degree of freedom 40. While the use of a screw head 31 with a convex profile and a screw hole 11 with a concave profile is disclosed herein to provide a fixation with a conical degree of freedom, it is appreciated that other methods exist in the art to achieve a fixation with similar properties. In some embodiments, the conical degree of freedom is between zero degrees and 90 degrees. In some embodiments, the conical degree of freedom is between and including 10 degrees and 70 degrees. In some embodiments, the conical degree of freedom is between and including 20 and 40 degrees. In some embodiments, the conical degree of freedom is between and including 25 and 35 degrees. In some embodiments, the conical degree of freedom is between and including 28 degrees and 32 degrees. In some embodiments, the conical degree of freedom is about 30 degrees.
The use of a screw head 31 with a convex profile and a screw hole 11 with a concave profile can also provide a fixation with an infinite number of degrees of freedom. In some embodiments, the bone screw 30 is fixed to a segment of tissue so that there is a clearance fit 50 between the screw head 31 and the screw hole 11. The clearance fit 50 allows the fixation plate 10 to rotate relative to the screw head 31 along any designed degree of freedom and an amount in the direction of the clearance fit 50. In some embodiments, it is desirable to use a clearance fit 50 of greater than zero between the screw head 31 and the screw hole 11 to prevent binding.
In some embodiments, the screw holes 11 are circular and smooth internally to allow the fixation plate 10 to rotate relative to the bone screws 30. The screw holes 11 can have a single diameter or a diameter gradient to accept specifically shaped bone screws 30. The screw holes 11 and bone screws 30 can optionally be configured to include rotational stops to constrain the rotation of the fixation plate 10 relative to a bone screw 30.
In
In the exemplary embodiment, the attachment port 22 further comprises an outer portion 23 and an inner portion 24. In some embodiments, the outer portion 23 is cylindrical, having a smaller diameter than the inner portion 24, also being cylindrical. The outer portion 24 can have one or more circular sectors where material has been removed in a radial direction that corresponds to areas on the cylindrical member 12 where material has been added in a radial direction. Material being added or removed can refer to the design process of a device or a process during manufacturing so that a device with material added can refer to a single continuous material and a device with material removed can refer to a device as manufactured.
In
In
In
In
What has been described is a fixation plate and an implant configured to accept the disclosed fixation plate. In this disclosure, there is shown and described only an exemplary embodiment of the invention, but, as aforementioned, it is to be understood that the invention is capable of use in various other combinations and environments and is capable of changes or modifications within the scope of the inventive concept as expressed herein.
This application claims the benefit of U.S. Provisional Patent Application No. 62/703,562 filed Jul. 26, 2018, which is hereby incorporated by reference in its entirety.
| Number | Name | Date | Kind |
|---|---|---|---|
| 5059193 | Kuslich | Oct 1991 | A |
| 5615528 | Owens | Apr 1997 | A |
| 5674294 | Bainville et al. | Oct 1997 | A |
| 6149688 | Brosnahan et al. | Nov 2000 | A |
| 6206924 | Timm | Mar 2001 | B1 |
| 6723126 | Berry | Apr 2004 | B1 |
| 6767594 | Miroshin et al. | Jul 2004 | B1 |
| 6902579 | Harms et al. | Jun 2005 | B2 |
| 7128760 | Michelson | Oct 2006 | B2 |
| 7172627 | Fiere | Feb 2007 | B2 |
| 7217293 | Branch, Jr. | May 2007 | B2 |
| 7637950 | Baccelli et al. | Dec 2009 | B2 |
| D619255 | Richter et al. | Jul 2010 | S |
| 7799079 | Hestad et al. | Sep 2010 | B2 |
| D626233 | Cipoletti et al. | Oct 2010 | S |
| 7850731 | Brittan et al. | Dec 2010 | B2 |
| 8043381 | Hestad et al. | Oct 2011 | B2 |
| D653757 | Binder | Feb 2012 | S |
| 8236058 | Fabian et al. | Aug 2012 | B2 |
| 8425576 | Anderson | Apr 2013 | B2 |
| D682427 | Farris et al. | May 2013 | S |
| D692136 | Tyber | Oct 2013 | S |
| 8663332 | To et al. | Mar 2014 | B1 |
| 8697231 | Longepied et al. | Apr 2014 | B2 |
| 8740983 | Arnold et al. | Jun 2014 | B1 |
| D708747 | Curran et al. | Jul 2014 | S |
| D711537 | Pimenta et al. | Aug 2014 | S |
| 8900307 | Hawkins et al. | Dec 2014 | B2 |
| 8945227 | Kirschman | Feb 2015 | B2 |
| 9005291 | Loebl et al. | Apr 2015 | B2 |
| D737446 | Butler et al. | Aug 2015 | S |
| 9155819 | Fonte et al. | Oct 2015 | B2 |
| 9186257 | Geisler | Nov 2015 | B2 |
| D750249 | Grimberg, Jr. et al. | Feb 2016 | S |
| 9271836 | Pavento | Mar 2016 | B2 |
| 9271843 | Fabian et al. | Mar 2016 | B2 |
| 9308076 | Ringeisen et al. | Apr 2016 | B2 |
| 9456901 | Jones et al. | Oct 2016 | B2 |
| 9492285 | Saidha et al. | Nov 2016 | B2 |
| 9566163 | Suddaby et al. | Feb 2017 | B2 |
| 9662225 | Pavento | May 2017 | B2 |
| D789539 | Kleiner et al. | Jun 2017 | S |
| 9668877 | Pavento | Jun 2017 | B2 |
| 9872781 | Pavento | Jan 2018 | B2 |
| D816844 | Ricca et al. | May 2018 | S |
| 9962269 | Jones et al. | May 2018 | B2 |
| 10045797 | Walkenhorst | Aug 2018 | B1 |
| D833012 | Jones et al. | Nov 2018 | S |
| D833611 | Jones et al. | Nov 2018 | S |
| D833612 | Jones et al. | Nov 2018 | S |
| 10130488 | Saidha et al. | Nov 2018 | B2 |
| D835279 | Jones et al. | Dec 2018 | S |
| D835788 | Jones et al. | Dec 2018 | S |
| D840036 | Jones et al. | Feb 2019 | S |
| 10368997 | Jones et al. | Aug 2019 | B2 |
| 10405983 | Jones et al. | Sep 2019 | B2 |
| 20020161444 | Choi | Oct 2002 | A1 |
| 20030114936 | Sherwood et al. | Jun 2003 | A1 |
| 20040162618 | Mujwid et al. | Aug 2004 | A1 |
| 20040243241 | Istephanous | Dec 2004 | A1 |
| 20040258732 | Shikinami | Dec 2004 | A1 |
| 20050049706 | Brodke et al. | Mar 2005 | A1 |
| 20050101960 | Fiere | May 2005 | A1 |
| 20050113916 | Branch | May 2005 | A1 |
| 20050129726 | Liebschner | Jun 2005 | A1 |
| 20050159813 | Molz | Jul 2005 | A1 |
| 20050251083 | Carr-Brendel et al. | Nov 2005 | A1 |
| 20060147332 | Jones et al. | Jul 2006 | A1 |
| 20060257817 | Shelton | Nov 2006 | A1 |
| 20060259144 | Trieu | Nov 2006 | A1 |
| 20060276925 | Lin et al. | Dec 2006 | A1 |
| 20070073398 | Fabian et al. | Mar 2007 | A1 |
| 20070123987 | Bernstein | May 2007 | A1 |
| 20070142914 | Jones et al. | Jun 2007 | A1 |
| 20070150068 | Dong et al. | Jun 2007 | A1 |
| 20070233247 | Schwab | Oct 2007 | A1 |
| 20070270858 | Trieu et al. | Nov 2007 | A1 |
| 20080161925 | Brittan | Jul 2008 | A1 |
| 20080161927 | Savage et al. | Jul 2008 | A1 |
| 20080169585 | Zinniel | Jul 2008 | A1 |
| 20080269903 | Francis et al. | Oct 2008 | A1 |
| 20080294262 | Levieux | Nov 2008 | A1 |
| 20080300634 | Gray | Dec 2008 | A1 |
| 20080306596 | Jones et al. | Dec 2008 | A1 |
| 20080306609 | Lee et al. | Dec 2008 | A1 |
| 20090012529 | Blain | Jan 2009 | A1 |
| 20090037148 | Lin et al. | Feb 2009 | A1 |
| 20090105831 | Jones | Apr 2009 | A1 |
| 20090182429 | Humphreys et al. | Jul 2009 | A1 |
| 20090287214 | Yu | Nov 2009 | A1 |
| 20090317278 | Kokubo | Dec 2009 | A1 |
| 20090326580 | Anderson | Dec 2009 | A1 |
| 20100087925 | Kostuik et al. | Apr 2010 | A1 |
| 20100100185 | Trieu et al. | Apr 2010 | A1 |
| 20100145459 | McDonough et al. | Jun 2010 | A1 |
| 20100234948 | Khoury et al. | Sep 2010 | A1 |
| 20100286783 | Lechmann et al. | Nov 2010 | A1 |
| 20110004307 | Ahn et al. | Jan 2011 | A1 |
| 20110012280 | Deslauriers et al. | Jan 2011 | A1 |
| 20110029084 | Milbocker et al. | Feb 2011 | A1 |
| 20110029087 | Haider et al. | Feb 2011 | A1 |
| 20110144764 | Bagga et al. | Jun 2011 | A1 |
| 20110190892 | Kirschman | Aug 2011 | A1 |
| 20110224796 | Weiland et al. | Sep 2011 | A1 |
| 20110282392 | Murphy et al. | Nov 2011 | A1 |
| 20120022653 | Kirschman | Jan 2012 | A1 |
| 20120123546 | Medina | May 2012 | A1 |
| 20120150299 | Ergun et al. | Jun 2012 | A1 |
| 20120177939 | Longepied et al. | Jul 2012 | A1 |
| 20120179258 | Glazer et al. | Jul 2012 | A1 |
| 20120185047 | Wooley | Jul 2012 | A1 |
| 20120215310 | Sharp et al. | Aug 2012 | A1 |
| 20120215313 | Saidha et al. | Aug 2012 | A1 |
| 20120303128 | Ullrich, Jr. et al. | Nov 2012 | A1 |
| 20120312779 | Patterson et al. | Dec 2012 | A1 |
| 20120321878 | Landon et al. | Dec 2012 | A1 |
| 20130026492 | Khan | Jan 2013 | A1 |
| 20130039094 | Kolb et al. | Feb 2013 | A1 |
| 20130060337 | Petersheim | Mar 2013 | A1 |
| 20130073044 | Gamache | Mar 2013 | A1 |
| 20130218276 | Fiechter et al. | Aug 2013 | A1 |
| 20130238095 | Pavento | Sep 2013 | A1 |
| 20130282126 | Saidha et al. | Oct 2013 | A1 |
| 20130310939 | Fabian et al. | Nov 2013 | A1 |
| 20130325129 | Huang | Dec 2013 | A1 |
| 20140012382 | Doty | Jan 2014 | A1 |
| 20140012384 | Kana | Jan 2014 | A1 |
| 20140037873 | Cheung et al. | Feb 2014 | A1 |
| 20140046447 | Dunworth | Feb 2014 | A1 |
| 20140046448 | Kana | Feb 2014 | A1 |
| 20140107786 | Geisler et al. | Apr 2014 | A1 |
| 20140121776 | Hunt | May 2014 | A1 |
| 20140277482 | Gfeller et al. | Sep 2014 | A1 |
| 20150005885 | Zhang et al. | Jan 2015 | A1 |
| 20150025635 | Laubert | Jan 2015 | A1 |
| 20150093283 | Miller et al. | Apr 2015 | A1 |
| 20150100126 | Melkent | Apr 2015 | A1 |
| 20150360421 | Burhop et al. | Dec 2015 | A1 |
| 20160000574 | Fabian et al. | Jan 2016 | A9 |
| 20160022431 | Wickham | Jan 2016 | A1 |
| 20160027425 | Cook et al. | Jan 2016 | A1 |
| 20160038301 | Wickham | Feb 2016 | A1 |
| 20160058480 | Laubert | Mar 2016 | A1 |
| 20160085882 | Li et al. | Mar 2016 | A1 |
| 20160113775 | Willis et al. | Apr 2016 | A1 |
| 20160166284 | Hacking et al. | Jun 2016 | A1 |
| 20160184103 | Fonte et al. | Jun 2016 | A1 |
| 20160199193 | Willis et al. | Jul 2016 | A1 |
| 20160206440 | DeRidder et al. | Jul 2016 | A1 |
| 20160235546 | Cheng | Aug 2016 | A1 |
| 20160270931 | Trieu | Sep 2016 | A1 |
| 20170014235 | Jones et al. | Jan 2017 | A1 |
| 20170020685 | Geisler | Jan 2017 | A1 |
| 20170042698 | Saidha et al. | Feb 2017 | A1 |
| 20170095337 | Pasini et al. | Apr 2017 | A1 |
| 20170119538 | Baynham | May 2017 | A1 |
| 20170312096 | Liu | Nov 2017 | A1 |
| 20170325966 | Capote | Nov 2017 | A1 |
| 20170348114 | Jones et al. | Dec 2017 | A1 |
| 20170367845 | Eisen et al. | Dec 2017 | A1 |
| 20180092752 | Williams | Apr 2018 | A1 |
| 20180140427 | Conway et al. | May 2018 | A1 |
| 20180221156 | Jones et al. | Aug 2018 | A1 |
| 20180228570 | Jones et al. | Aug 2018 | A1 |
| 20180228612 | Jones et al. | Aug 2018 | A1 |
| 20180228613 | Jones et al. | Aug 2018 | A1 |
| 20180243094 | Jones et al. | Aug 2018 | A1 |
| 20180243097 | Jones et al. | Aug 2018 | A1 |
| 20180280139 | Jones et al. | Oct 2018 | A1 |
| 20180280140 | Jones et al. | Oct 2018 | A1 |
| 20180280141 | Jones et al. | Oct 2018 | A1 |
| 20180280144 | Jones et al. | Oct 2018 | A1 |
| 20180280145 | Jones et al. | Oct 2018 | A1 |
| 20180296350 | Hamzey et al. | Oct 2018 | A1 |
| 20180318099 | Altarac | Nov 2018 | A1 |
| 20180318100 | Altarac | Nov 2018 | A1 |
| 20180368990 | Saidha et al. | Dec 2018 | A1 |
| 20180368992 | Zink | Dec 2018 | A1 |
| 20190133778 | Johnston | May 2019 | A1 |
| 20190133783 | Unger et al. | May 2019 | A1 |
| 20190150910 | Jones et al. | May 2019 | A1 |
| 20190209215 | Baynham | Jul 2019 | A1 |
| 20190250438 | Oton et al. | Aug 2019 | A1 |
| 20190343638 | Jones et al. | Nov 2019 | A1 |
| 20190343644 | Ryan et al. | Nov 2019 | A1 |
| 20200000595 | Jones et al. | Jan 2020 | A1 |
| 20200038069 | Jones | Feb 2020 | A1 |
| 20200138595 | Shoshtaev | May 2020 | A1 |
| 20200281736 | Milz | Sep 2020 | A1 |
| Number | Date | Country |
|---|---|---|
| 204971711 | Jan 2016 | CN |
| 1506753 | Feb 2005 | EP |
| 2647453 | Oct 2013 | EP |
| 1887954 | Sep 2014 | EP |
| WO-1999033641 | Jul 1999 | WO |
| WO-0217823 | Mar 2002 | WO |
| WO-2014160389 | Oct 2014 | WO |
| WO-2014172495 | Oct 2014 | WO |
| WO-2015164982 | Nov 2015 | WO |
| WO-2016061148 | Apr 2016 | WO |
| WO-2016130878 | Aug 2016 | WO |
| WO-2017214114 | Dec 2017 | WO |
| WO-2018152077 | Aug 2018 | WO |
| WO-2018156905 | Aug 2018 | WO |
| WO-2018182834 | Oct 2018 | WO |
| WO-2018183809 | Oct 2018 | WO |
| WO-2020023938 | Jan 2020 | WO |
| Entry |
|---|
| U.S. Appl. No. 15/615,227, filed Jun. 6, 2017, Christopher L. Jones. |
| U.S. Appl. No. 15/942,846, filed Apr. 2, 2018, Christopher L. Jones. |
| U.S. Appl. No. 15/876,695, filed Jan. 22, 2018, Christopher L. Jones. |
| U.S. Appl. No. 15/876,793, filed Jan. 22, 2018, Christopher L. Jones. |
| U.S. Appl. No. 15/876,903, filed Jan. 22, 2018, Christopher L. Jones. |
| U.S. Appl. No. 15/877,002, filed Jan. 22, 2018, Christopher L. Jones. |
| U.S. Appl. No. 16/251,383, filed Jan. 18, 2019, Christopher L. Jones. |
| U.S. Appl. No. 16/518,281, filed Jan. 22, 2019, Christopher L. Jones. |
| U.S. Appl. No. 16/917,685, filed Jun. 30, 2020, Christopher L. Jones. |
| U.S. Appl. No. 15/895,201, filed Feb. 13, 2018, Christopher L. Jones. |
| U.S. Appl. No. 15/895,213, filed Feb. 13, 2018, Christopher L. Jones. |
| U.S. Appl. No. 15/895,228, filed Feb. 13, 2018, Christopher L. Jones. |
| U.S. Appl. No. 16/565,321, filed Sep. 9, 2019, Christopher L. Jones. |
| U.S. Appl. No. 15/903,648, filed Feb. 23, 2018, Christopher L. Jones. |
| U.S. Appl. No. 15/903,667, filed Feb. 23, 2018, Christopher L. Jones. |
| U.S. Appl. No. 15/941,193, filed Mar. 3, 2018, Christopher L. Jones. |
| U.S. Appl. No. 16/744,103, filed Jan. 15, 2020, Christopher L. Jones. |
| Ahmadi, S. et al., “Additively Manufactured Open-Cell Porous Biomaterials Made from Six Different Space-Filling Unit Cells: The Mechanical and Morphological Properties,” Materials, vol. 8:1871-1896 (2015). |
| Babaee S., et al., “Mechanical properties of open-cell rhombic dodecahedron cellular structures,” Acta Materialia, vol. 60:2873-2885 (2012). |
| Chandran R.; “Optimization of Support Structures in Additive Manufacturing Process”, Dissertation, University of Miami, 2016 (Year:2016). |
| European Search Report, 17810838.7, dated Dec. 19, 2019, 8 pages. |
| Hoffmann, W. et al., “Rapid prototyped porous nickel-titanium scaffolds as bone substitutes,” Journal of Tissue Engineering, vol. 5:1-14 (2014). |
| International Preliminary Report on Patentability, PCT/US2017/36111, dated Jun. 27, 2018, 26 pages. |
| International Search Report and Written Opinion, PCT /US2017/36111, dated Nov. 6, 2017, 10 pages. |
| International Search Report and Written Opinion, PCT/US2018/017919, dated Jun. 6, 2018, 14 pages. |
| International Preliminary Report on Patentability, PCT/US2018/017919, dated Aug. 20, 2019, 11 pages. |
| International Preliminary Report on Patentability, PCT/US2018/019437, dated Aug. 27, 2019, 16 pages. |
| International Search Report and Written Opinion, PCT/US2018/019437, dated Jun. 28, 2018, 19 pages. |
| International Search Report and Written Opinion, PCT/US2018/014720, dated Jun. 1, 2018, 13 pages. |
| International Search Report and Written Opinion, PCT/US2018/025351, dated Jun. 8, 2018, 14 pages. |
| International Search Report and Written Opinion, PCT/US2019/043803, dated Nov. 7, 2019, 11 pages. |
| Leary M., et al.; “Optimal topology for additive manufacture: A method for enabling additive manufacture of support-free optimal structures”, Materials and Design, 2014, vol. 63, p. 678-690 (Year: 2014). |
| Nouri, A., “Titanium foam scaffolds for dental applications,” Metallic Foam Bone, Chapter 5: 130-160 (2017) http://dx.doi.org/10.1016/B978-0-08-101289-5.00005-6. |
| Strano G., et al.; “A new approach to the design and optimization of support structures in additive manufacturing”, Int. J. Adv Manufacturing Technology, 2013, 66, p. 1247-1254 (Year: 2013). |
| Stryker, “Tritanium PI Cage”, Technical Data Sheet, https://www.stryker.com/builttofuse/; retrieved from wayback machine on Apr. 23, 2021; date Jun. 21, 2016. |
| Zhang,X., et al., “Additively Manufactured Scaffolds for Bone Tissue Engineering and the Prediction of their Mechanical Behavior: A Review,” Materials, 10(10): 1-28 (2017). |
| U.S. Appl. No. 16/518,281, filed Jul. 22, 2019, Christopher L. Jones. |
| Number | Date | Country | |
|---|---|---|---|
| 20200038069 A1 | Feb 2020 | US |
| Number | Date | Country | |
|---|---|---|---|
| 62703562 | Jul 2018 | US |
